Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-19-006616

Director bought 3,500 shares at $22.33 ($78,155)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Saad Mark E Director 2019-05-23 Purchase +3,500 $22.33 $78,155 7,002 D: show line 1 in the form
Open-market purchases · 3,500 sh · avg $22.33 · $78,155
Loading xslF345X03/edgar.xml…